Literature DB >> 32609746

Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.

Ikuko Takahara, Yuko Akazawa, Maiko Tabuchi, Katsuya Matsuda, Hisamitsu Miyaaki, Youko Kido, Yasuko Kanda, Naota Taura, Ken Ohnita, Fuminao Takeshima, Yusuke Sakai, Susumu Eguchi, Masahiro Nakashima, Kazuhiko Nakao.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0170591.].

Entities:  

Year:  2020        PMID： 32609746      PMCID： PMC7329070          DOI： 10.1371/journal.pone.0235729

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


  1 in total

1.  Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.

Authors:  Ikuko Takahara; Yuko Akazawa; Maiko Tabuchi; Katsuya Matsuda; Hisamitsu Miyaaki; Youko Kido; Yasuko Kanda; Naota Taura; Ken Ohnita; Fuminao Takeshima; Yusuke Sakai; Susumu Eguchi; Masahiro Nakashima; Kazuhiko Nakao
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.